Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr Yasser Ismail Mostafa Abdelaziz

Dr Yasser Ismail Mostafa Abdelaziz

Saudi Arabia

Recommended Global Pulmonology Webinars & Conferences

Europe & UK
Asia Pacific & Middle East


About Conference

ME Conferences invites all the participants from all over the world to attend 12th International Conference on Chronic Obstructive Pulmonary Disease (COPD) during October 09-10, 2023 Prague, Czech Republic. This meeting deals with the advanced research technologies in the field of pulmonology and also about the new treatment approaches which are formulated by scientists to treat numerous diseases in an easier method which includes encouraging keynote presentation, Oral speech, Poster presentations, Exhibitions.

The main theme of the conference is “Scrutinizing the challenges and developing novel approaches for COPD treatment”. This would be a two days conference which prompts the minds of attendees.

Why to attend? 

International Conference on Chronic Obstructive Pulmonary Disease aims to bring together globally distinguished academics in the field of Pulmonologists, Pulmonaryspecialists, Respiratoryspecialist,  paediatric pulmonologists, Public Health professionals, Scientists, Academic scientists, Researchers, Intellectuals, to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. To understand the  current state of research and the challenges to future discovery.

     Target Audience:

  • Directors/CEO & Research Scientists 
  • Pulmonologists, Respiratory Therapists
  • Lung and respiratory Researchers
  • Pulmonology Faculty and Students
  • Lung and Respiratory Associations and Societies
  • Business Entrepreneurs
  • Thoracic surgeons, Radiologists
  • Medical and Nursing Students, Professors
  • Pharmaceutical companies
  • Manufacturing Medical Devices Companies
  • Paediatric pulmonologists


Track 1: Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) causes when there is long term exposure to irritants that damage your lungs and airways. It comprises chronic bronchitis and emphysema. Emphysema is a disease of alveoli, making the alveoli lose its elasticity and Chronic Bronchitis is a condition where the Inflammation in the bronchial tube takes place .COPD  is an abiding  lung disease that makes one hard to breathe. COPD is a prevalent condition which mainly affects adults who smoke. Breathing in smoke and the chemicals can damage  the airways and air sacs.

Track 2: Respiratory Diseases

Respiratory Diseases are pathological conditions affecting the organs and tissues that make gas (Oxygen and Carbon dioxide) exchange difficult in respiration. Common respiratory diseases are Chronic obstructive pulmonary disease, Asthma, Pneumonia, Bronchitis, Cystic Fibrosis, Tuberculosis. Among all the respiratory diseases, about 65 million people suffer from chronic obstructive pulmonary disease (COPD).

Track 3: Lung Cancer

Cancer is a disease where in the cells of  the body grow out of control. When cancer observed in the lungs, it is called lung cancer. Lung cancers usually are categorized into two main types called small cell and non-small cell. These two types of lung cancer grow differently and are treated differently. Non-small cell lung cancer is more prominent than small cell lung cancer The recommended screening test for lung cancer is low-dose computed tomography

Track 4: Asthma

Asthma is a long-term problem in the tubes that carry air into the lungs that can make it hard to breathe. The airways get narrow , so air cannot move easily. It can source serious wheezing and breathlessness, known as asthma attacks. Peak flow score will give a sign warn that an asthma attack might happen soon. Most people can control their symptoms. Asthmatic  patient need to take medicine every day to prevent asthma attacks.

Track 5: Pulmonary Infectious Diseases

Pulmonary Infectious diseases occur when the lungs are infected with bacteria,  virus, or  fungus. Some types of Chronic Pulmonary Infections are Tuberculosis, Pneumonia, Histoplasmosis, Pleural Effusion, Pulmonary infections are treatable, particularly when diagnosed early. Many other infections or diseases may also mimic these infections Fevers for more than a week Cough for more than three weeks, Swollen lymph nodes (glands) in your neck, Coughing up blood.

Track 6: Pathology of Pulmonary Diseases

The histology of pathologic descriptions of the lung  disease that is now known as COPD. It describes the pathology and the description of emphysema and its diversity from tuberculosis The diseases that lead to COPD include emphysema, chronic bronchitis, and refractory asthma. All of these has different effects on the lungs and respiratory system. It is a progressive condition, where in the meaning that it gets worse over time.

Track 7: Epidemiology of COPD    

Smoking remains the most prominent risk factor for COPD in world, other risk factors, including genetic factors and occupational or environmental exposures, remain important. COPD remains a grave public health problem that is regularly underdiagnosed, particularly in its early stages. The respiratory indications of cough and phlegm amplified with existing smoking and age among both in  men and women

Track 8: Immune Responses in COPD

Chronic inflammation  and immune responses play a vital  roles in the development and advancement of COPD. The role in the NLRP3 inflammasome in the airway inflammation is observed in COPD. The exposure to cigarette smoke, toxic particles and  gases will activate an inflammatory response in the airways occasioning in the production of a number of potent cytokines and chemokines which play a major role in the stimulation of chronic inflammation and consequent tissue devastation

Track 9: Genetics of COPD

There are many factors can contribute to the occurrence of COPD. Despite the fact cigarette smoking is the number one risk factor in the progression of COPD, recent research has pointed to the concept that genes also play a significant role. A small but vital segment of COPD cases anchorage a major genetic determinant, α1-antitrypsin deficiency (AATD). Intravenous administration with AAT protein is a commonly used treatment for severe AATD in COPD patients.

Track 10: Paediatric Pulmonology

Paediatric respiratory medicine is a multidisciplinary subspecialty in the specialty of paediatrics, which involves doctors, nurses, respiratory physiologists, physiotherapists, the child. The major reason Paediatric pulmonology is arose relatively late as a specialty of paediatrics is because respiratory problems were so common in the children that all paediatricians were estimated to be specialists in their diagnosis, treatment and management. The majority of paediatric respiratory illnesses are mild and has resolution on their own or respond to treatment given in primary care.


Market Analysis

Market Shares of COPD and Asthma:

According to the current research Global Asthma and COPD Therapies market shares in coming years is expected to be increased by the percentage. As now US is the highest developing therapeutics for the chronic respiratory disorders is 40% all over the world.

Leading causes of death in worldwide

Over the million deaths worldwide, more than half (54%) were due to the top 10 causes. Ischaemic heart disease and stroke are the world’s biggest killers, another main reason accounting for death is Chronic Obstructive Pulmonary Disease. These diseases have remained the leading causes of death globally in the last 15 years.

Risk factors of Chronic Respiratory Diseases:

In addition to tobacco smoke, other risk factors include air pollution, occupational chemicals and dusts, and frequent lower respiratory infections during childhood. CRDs are not curable, however, various forms of treatment that help dilate major air passages and improve shortness of breath can help control symptoms and increase the quality of life for people with the disease

Industries Associated with Lung and Respiratory Care Worldwide:

  • GlaxoSmithKline
  • Pfizer
  • Sanofi-Aventis
  • AstraZeneca
  • Novartis
  • Roche
  • Wyeth
  • Merk & Co
  • Lilly
  • Boehringer Ingelheim
  • Johnson & Johnson
  • Schering Plough
  • Novo Nordisk
  • Bayer Schering
  • Abbott
  • Teva
  • Bristol-Myers Squibb
  • Mundi Int
  • Gilead Sciences
  • Servier
  • Edwards Lifesciences
  • British American Tobacco
  • Imperial Tobacco Group
  • Reckitt Benckiser Group
  • Acm Global Central Laboratory Services Ltd
  • Acorn Polymers (UK) Ltd
  • Access Health Products
  • Acm Global Central Laboratory Services Ltd
  • Acorn Equipment Co Ltd

Industries in Middle East:

  • Neo Pharmaceutical plant, UAE
  • Med Pharma
  • Pfizer, UAE
  • Merck, UAE
  • Ranbaxy Laboratories Limited
  • Himka Pharmaceuticals Limited
  • Elis Pharmaceutical Limited
  • Gen Pharma
  • Amgen

Industries in Dubai:

  • Dayarm Pharma
  • Julphar Life
  • Novo Nordisk
  • Pharma Gulf Fz LIC
  • Abbott Laboratories S.A.
  • Sanofi Aventis UAE
  • Alliance Global
  • Glaxo Smith Kine
  • Saga Pharmaceuticals



To Collaborate Scientific Professionals around the World

Conference Date October 09-10, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by